← FDA DRUG APPROVALS

FDA ANDA · ANDA074348

CHOLESTYRAMINE LIGHT

Sponsor: TEVA

APPLICATION
ANDA074348
TYPE
ANDA
ORIGINAL APPROVAL
1998-05-28
LATEST ACTION
2001-12-20
ROUTE
ORAL
DOSAGE FORM
POWDER
MARKETING STATUS
Discontinued

Products

CHOLESTYRAMINE LIGHTDiscontinued
CHOLESTYRAMINE EQ 4GM RESIN/SCOOPFUL · POWDER · ORAL
CHOLESTYRAMINE LIGHTDiscontinued
CHOLESTYRAMINE EQ 4GM RESIN/PACKET · POWDER · ORAL

Approval history

2001-12-20Manufacturing (CMC) · Supplement 1AP
1998-05-28Original — Letter ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →